
Specialization can lead to big gains.
Compare up to 20 ETFs
Compared Stocks: 1 / 20
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| IHE | iShares U.S. Pharmaceuticals ETF | 109.64 | 29.83 | 37.38% |
| Name | Price | % Change | |
|---|---|---|---|
| $109.64 | +37.38% |

Specialization can lead to big gains.

Healthcare is diverse sector of the economy.

Pharma is one of the most exciting areas of healthcare.

There are many sectors within the health category.

Johnson & Johnson ($JNJ) is set to report its Q4 earnings on January 21. Analysts expect revenue of about $24.16 billion, up 7.3% year‑over‑year, and earnings of $2.49 per share, reflecting a

In a significant meeting at the White House on April 3rd, President Biden and Senator Bernie Sanders joined forces to assert control over pharmaceutical pricing, potentially influencing stock market valuations

Investing in exchange-traded funds (ETFs) offers exposure to various asset classes, sectors, or markets through a single investment vehicle. It also provides flexibility and lower investment costs in comparison to
The Ultimate ETF Comparison Tool: Analyze Fees, Performance & Holdings
Choosing the right ETF (Exchange Traded Fund) can be difficult with thousands of options available. The TipRanks ETF Comparison Tool allows you to evaluate funds side-by-side to find the best fit for your portfolio. Whether you are deciding between S&P 500 giants like VOO vs. SPY or hunting for high-yield income funds like SCHD vs. JEPI, our tool breaks down the critical data points that matter most.
5 Key Metrics to Look for When Comparing ETFs
How to Use the TipRanks ETF Analyzer
Step 1: Enter the ticker symbols (e.g., VTI, IVV, ARKK) in the search bar above.
Step 2: Select 'Add to Compare' to build your custom view (compare up to 10 funds at once).
Step 3: Toggle between the 'Dividends' tab to check payment history and the 'Technical Analysis' tab to see momentum indicators like RSI and Moving Averages.
Step 4: Check the 'Analyst Consensus' column. This proprietary metric aggregates the buy/sell ratings of the individual stocks held within the ETF, giving you a unique 'Wall Street' view of the fund's potential.